中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 6
Jun.  2019
Turn off MathJax
Article Contents

The biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis

DOI: 10.3969/j.issn.1001-5256.2019.06.040
  • Received Date: 2018-12-07
  • Published Date: 2019-06-20
  • Liver fibrosis is a necessary stage in the development of chronic liver diseases to liver cirrhosis. Liver cirrhosis is the end-stage change of various chronic liver diseases, and early diagnosis of liver fibrosis has an important value in timely treatment and prognosis. At present, liver biopsy, ultrasound, computed tomography, and magnetic resonance imaging are the main diagnostic methods for liver fibrosis and cirrhosis. Liver biopsy is the gold standard for the diagnosis of liver fibrosis and cirrhosis, but its clinical application is limited by invasiveness and sample error. Conventional noninvasive methods cannot meet the requirements for the diagnosis of liver fibrosis and cirrhosis.Therefore, searching for new serological markers for liver fibrosis and cirrhosis has become a research hotspot. Related studies have shown that serum Golgi protein 73 (GP73) can be used as a serum marker for the diagnosis of liver fibrosis and cirrhosis and has high clinical value. This article reviews the commonly used methods for the diagnosis of liver fibrosis and cirrhosis and elaborates on the biological characteristics of GP73 and its value in the diagnosis of liver fibrosis and cirrhosis.

     

  • loading
  • [1]LACKNER C, KNISELY AS.Liver biopsy in children and adolescents:Preliminary morphological examinations in diffuse liver disease[J].Pathologe, 2017, 26 (6) :1316-1324.
    [2]POORTEN VD, KORK A, LAM T, et al.Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital[J].Intern Med J, 2010, 36 (11) :692-699.
    [3]PICCININO F, SAGNELLI E, PASQUALE G, et al.Complications following percutaneous liver biopsy.A multicentre retrospective study on 68, 276 biopsies[J].J Hepatol, 1986, 2 (2) :165-173.
    [4]KOCAB M, NORD H, BRANTLEY S, et al.Prospective randomized single-blinded evaluation of adequacy of percutaneous liver biopsy by standard Menghini-type (SM) and spring-loaded-type (SL) needles[J].Gastroenterology, 1998, 114 (4) :A1277.
    [5]STOECKHERT E.Liver biopsy:Is it still relevant?[J].Intern Med J, 2010, 36 (11) :689-691.
    [6]EMANUELE E.Is biopsy always necessary?Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity[J].Hepatology, 2010, 48 (6) :2086-2087.
    [7]HUANG FC.Ultrasound diagnosis for 198 psychiatric patients with fatty liver and result analysis[J].Med J Chin People’s Health, 2014, 26 (24) :25-26. (in Chinese) 黄福春.超声诊断精神科脂肪肝患者198例结果分析[J].中国民康医学, 2014, 26 (24) :25-26.
    [8]LIANG W, TANG HL, QUAN XY, et al.Preliminary application of 64-slice spiral CT whole-liver perfusion in hepatocellular carcinoma[J].Chin J Med Imaging Technol, 2007, 23 (5) :707-710. (in Chinese) 梁文, 唐海亮, 全显跃, 等.64层螺旋CT全肝灌注模式成像在肝细胞癌中的初步应用[J].中国医学影像技术, 2007, 23 (5) :707-710.
    [9]RONOT M, AHSSEL TV, MICHOUX N, et al.Liver fibrosis in chronic hepatitis C virus infection:Differentiating minimal from intermediate fibrosis with perfusion CT[J].Radiology, 2010, 256 (1) :135-142.
    [10]LONG LL, HUANG ZK, DING K, et al.Application value multi-slice spiral CT liver perfusion imaging in the chronic hepatic fibrosis and cirrhosis[J].Chin J Radiol, 2012, 46 (4) :317-321. (in Chinese) 龙莉玲, 黄仲奎, 丁可, 等.多层螺旋CT肝脏灌注成像评价慢性肝纤维化、肝硬化的价值[J].中华放射学杂志, 2012, 46 (4) :317-321.
    [11]NIU M, DENG DY, LI YPF, et al.Values of MRE in diagnosis of stages of hepatic fibrosis:A Meta-analysis[J].J Jilin Univ:Med Edit, 2017, 43 (4) :787-793. (in Chinese) 牛猛, 邓大勇, 李云鹏飞, 等.磁共振弹性成像对肝纤维化分级诊断分值的Meta分析[J].吉林大学学报:医学版, 2017, 43 (4) :787-793.
    [12]PETITCLERC L, SEBASTIANI G, GILBERT G, et al.Liver fibrosis:Review of current imaging and MRI quantification techniques[J].JMRI, 2017, 45 (5) :1276.
    [13]LI ZB, SHAO Q, ZHANG J, et al.Study on the influence of alanine transaminase to the accuracy of hepatic hardness diagnosed by FibroScan[J].Prog Mod Biomed, 2012, 12 (36) :7040-7043. (in Chinese) 李忠斌, 邵清, 张健, 等.丙氨酸转氨酶对FibroScan诊断肝硬度准确性的影响[J].现代生物医学进展, 2012, 12 (36) :7040-7043.
    [14]KLADNEY RD, BULLA GA, GUO L, et al.GP73, a novel Golgi-localized protein upregulated by viral infection[J].Gene, 2000, 249 (1) :53-65.
    [15]WRIGHT LM, YONG S, PICKEN MM, et al.Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2) [J].Int J Clin Exp Pathol, 2009, 2 (1) :34-47.
    [16]KLADENY RD, CUI X, BULLA GA, et al.Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease[J].Hepatology, 2002, 35 (6) :1431-1440.
    [17]BACHERT C, FIMMEL C, LINSTEDT AD.Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma[J].Traffic, 2010, 8 (10) :1415-1423.
    [18] KLADNEY RD, CUI X, BULLA GA, et al.Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease[J].Hepatology, 2002, 35 (6) :1431-1440.
    [19]WEI HS, KANG YF, HAO XH, et al.Serum GP73 were increased in patients with fatty liver disease[J].Chin J Exp Clin Virol, 2013, 27 (4) :244-246. (in Chinese) 魏红山, 康艳芳, 郝晓花, 等.肝细胞脂肪变对血清糖蛋白GP73水平的影响[J].中华实验和临床病毒学杂志, 2013, 27 (4) :244-246.
    [20]IFTIKHAR R, KLADNEY RD, HAVLIOGLU N, et al.Diseaseand cell-specific expression of GP73 in human liver disease[J].Am J Gastroenterol, 2004, 99 (6) :1087.
    [21]MAO Y, YANG H, XU H, et al.Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma[J].Gut, 2010, 59 (12) :1687-1693.
    [22]CAO Z, LI Z, WANG H, et al.Algorithm of Golgi protein 73and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection[J].Liver Int, 2017, 37 (11) :1612.
    [23]FARCI P, WOLLENBERG K, DIAZ G, et al.Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis[J].Proc Natl Acad Sci U S A, 2012, 109 (36) :14562-14567.
    [24] LUO KX, CHEN JJ, LI P.Hepatitis B basic biology and clinical science[M].Beijing:People’s Medical Publishing House, 1997:397. (in Chinese) 洛抗先, 陈金军, 李平.乙型肝炎基础与临床[M].北京:人民卫生出版社, 1997:397.
    [25]XU ZJ, PAN XN, WEI KP, et al.Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B[J].Mol Med Rep, 2015, 11 (4) :2644-2652.
    [26]XU Z, LIU L, PAN X, et al.Serum Golgi proetopancreatobiliaatein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease[J].Medicine, 2015, 94 (12) :e659.
    [27]YAO MJ, WANG LJ, GUAN GW, et al.Value of serum Golgi protein 73 in assisting the diagnosis of moderate or severe liver injury in patients with chronic hepatitis B[J].J Clin Hepatol, 2018, 34 (4) :755-759. (in Chinese) 姚明解, 王雷婕, 关贵文, 等.血清高尔基体蛋白73在辅助诊断慢性乙型肝炎患者中度以上肝损伤中的应用[J].临床肝胆病杂志, 2018, 34 (4) :755-759.
    [28]WEI H, LI B, ZHANG R, et al.Serum GP73, a marker for evaluating progression in patients with chronic HBV infections[J].PLo S One, 2013, 8 (2) :e53862.
    [29]WEISKIRCHEN R, TACKE F.Combining GP73 with liver stiffness measurements:A proof-of-concept for non-invasive fibrosis assessment in antiviral-na6ve HBV patients[J].Liver Int, 2017, 37 (11) :1605.
    [30]QIAO Y, CHEN J, LI X, et al.Serum GP73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection[J].Clin Biochem, 2014, 47 (16-17) :216-222.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1861) PDF downloads(237) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return